[저자] Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C deCamp, Zonglin He, Nicole Grunenberg, Faatima Laher Omar, Kelly E Seaton, Laura Polakowski, Amanda S Woodward Davis, Lucas Maganga, Lindsey R Baden, Kenneth Mayer, Spyros Kalams, Michael Keefer, Srilatha Edupuganti, Benigno Rodriguez, Ian Frank, Hyman Scott, Lynda Stranix-Chibanda, Sanjay Gurunathan, Marguerite Koutsoukos, Olivier Van Der Meeren, Carlos A DiazGranados, Carmen Paez, Erica Andersen-Nissen, James Kublin, Lawrence Corey, Guido Ferrari, Georgia Tomaras, M Juliana McElrath
[Category] 대상포진,
[Article Type] Major Article Viruses
[Source] PMC
We report results of HIV vaccine trial HVTN 120, which evaluated ALVAC-HIV (vCP2438) boosted with MF59 or AS01 B} adjuvanted with gp120 at 2 doses. The highest CD4^{+} T-cell and binding antibody responses were in the lower dose gp120/AS01 B} regimen.
All Keywords
【저자키워드】 HIV, Vaccine, adjuvant, dose,